TNBC (HR- HER2-) Adjuvant

HIGH RISKPREFERREDALTERNATEALTERNATEALTERNATESTARTFINISHCreated with SnapHR negative, HER2negative (TNBC)≥pN1 or pN0 pT>1cmAdjuvantSTARTFINISHCreated with SnapSequentialanthracycline (EC)and PaclitaxelCarboplatinSTARTFINISHCreated with SnapSequentialanthracycline (EC)and taxane (Paclitaxelor Docetaxel)STARTFINISHCreated with SnapDocetaxel andCarboplatinSTARTFINISHCreated with SnapIf BRCA mutationpositive, consideradjuvant olaparibSTARTFINISHCreated with SnapEpirubicin andCyclophosphamideSTARTFINISHCreated with SnapDocetaxel andCyclophosphamide